相关实验视频
Updated: Jun 28, 2025

05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
37.3K
大型抑郁症中塞特拉林和西塔洛普拉姆疗效的性别控制差异:一项随机双盲试验
Ahmad Shamabadi1, Hanie Karimi1, Mohammad Ali Fallahzadeh1
1Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran.
International clinical psychopharmacology
|April 19, 2024
概括
这项研究发现,性影响大脑衍生神经营养因子 (BDNF) 在接受塞特拉林或西塔洛普拉姆治疗的大型抑郁症患者的水平. 男性的BDNF在使用塞特拉林时显著增加,这表明性作为抗抑郁药反应中的效果修饰剂.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 对抗抑郁药反应的性别差异是有争议的.
- 大型抑郁症 (MDD) 影响全球数百万人.
- 像BDNF,IL-6和皮质醇这样的生物标志物可以预测治疗结果.
研究的目的:
- 为了调查男性和女性的抗抑郁药反应,控制性.
- 为了比较sertraline和citalopram在MDD患者中的疗效.
- 为了检查治疗对BDNF,IL-6和皮质醇水平的影响,考虑性别.
主要方法:
- 这是一项为期8周的随机,并行组,双盲临床试验,涉及92名MDD门诊患者.
- 参与者被分配给塞特拉林 (100毫克/天) 或西塔洛普拉姆 (40毫克/天).
- 评估包括汉密尔顿抑郁评分表 (HDRS) 评分和BDNF,IL-6和皮质醇的血清水平.
主要成果:
- 塞特拉林和citalopram之间整体治疗结果没有显著差异.
- 在BDNF水平 (P=0.035) 中观察到一个显著的时间治疗性相互作用效应.
- 亚组分析显示,男性BDNF与塞特拉林 (P=0.020) 显著增加,效果大小中等至大.
结论:
- 性行为作为一个效果修饰在BDNF改变在塞特拉林和citalopram治疗MDD.
- 在接受塞特拉林的人群中,IL-6和BDNF变化之间发现了显著的关联.
- 建议进行进一步的大规模,长期的研究来证实这些发现.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
380
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
380
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
134
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
134
Antidepressant Drugs: Overview
466
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
466
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
249
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
249
Panic Disorder
110
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
110

